Cullinan Therapeutics, Inc.

CGEM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$16.25-1.52%

2026-08-03

Financials

Valuation Metrics

Cullinan Therapeutics, Inc.'s Market Cap is $999M. At end of 2025 it was $613M. Ranked #2500 of 3,112 in US market (top 80%), #1029 of 1,445 on NASDAQ (top 71%), #191 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 71%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$999M	US#2,500/3,112 Sec#191/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-221M	US—/3,112 Sec—/269
Total Assets	$403M	US#2,822/3,112 Sec#183/269
Net Assets	$366M	US#2,452/3,112 Sec#146/269
Value
P/B	2.73x	US#1,566/3,112 Sec#79/269
FCF Yield	-17.89%	US—/3,112 Sec—/269
Profitability
ROE	-60.36%	US#2,775/3,112 Sec#188/269
ROA	-54.85%	US#2,983/3,112 Sec#227/269
Financial Health
Debt Ratio	10.05%	US#113/3,112 Sec#49/269
Total Debt	$2M	US#2,898/3,112 Sec#234/269
FCF	$-179M	US#2,714/3,112 Sec#208/269
Cash	$75M	US#2,374/3,112 Sec#198/269
Current Ratio	10.28x	US#242/3,112 Sec#77/269
Performance
1Y Return	111.86%	US#286/3,112 Sec#78/269
1M Return	-7.83%	US#2,468/3,112 Sec#147/269
From 52W High	-16.37%	US#1,490/3,112 Sec#87/269
1Y MDD	-36.67%	US#1,787/3,112 Sec#127/269
Trading
Volume	366,444 shares	US#2,286/3,112 Sec#223/269
Trading Value	$6M	US#2,598/3,112 Sec#212/269
Per Share
EPS	$-3.71	US—/3,112 Sec—/269
BPS	$6.90	US#2,051/3,112 Sec#104/269